Coronavirus live updates: Major late-stage vaccine trial paused; drugmakers pledge to prioritize safety

Health, Fitness & Food

Nine drugmakers working on coronavirus vaccines publicly pledged on Tuesday to prioritize safety and uphold rigorous scientific standards as concerns mount of political pressure to bring a vaccine to market before the Nov. 3 U.S. presidential election. The pledge sought to “ensure public confidence” by committing to only apply for regulatory authorization when enough data has been collected from a large phase three trial. Three vaccine manufacturers have now entered phase three trials. 

The following data was compiled by Johns Hopkins University:

  • Global cases: More than 27.3 million
  • Global deaths: At least 893,00
  • U.S. cases: More than 6.3 million
  • U.S. deaths: At least 189,200

Products You May Like

Articles You May Like

Johnson & Johnson enters late-stage trial testing its coronavirus vaccine
It’s not entirely clear how the government will pay for Trump’s $200 Medicare cards
Trump’s coronavirus vaccine czar says he’s had ‘enough’ of Democratic calls for his firing over pharma stock holdings
Fewer than 10% of Americans show signs of past coronavirus infection, study finds
Everyone thought Germany and Italy weren’t seeing a second wave of the coronavirus … now maybe they are

Leave a Reply

Your email address will not be published. Required fields are marked *